HeartSciences Inc. - Common Stock (NQ:HSCS)

2.110 -0.070 (-3.21%)

Streaming Delayed Price Updated: 2:09 PM EDT, Aug 3, 2026 Add to My Watchlist

Price and Volume

Volume	44,422
Open	2.160
Bid (Size)	2.110 (500)
Ask (Size)	2.150 (300)
Prev. Close	2.180
Today's Range	2.092 - 2.280
52wk Range	1.630 - 3.930
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Fortitude Purchases 9,000 Bitmain Antminer Z15 Pro Units, Deepening Commitment to the Zcash Ecosystem

July 30, 2026

From Fortitude Mining Holdings, Inc.

Via Business Wire

HeartSciences Files Preliminary Proxy Statement for Business Combination with Fortitude Mining Holdings; Provides Business Update and Reports Fiscal 2026 Financial Results

July 29, 2026

From HeartSciences Inc.

Via GlobeNewswire

Performance

YTD	-32.8%	-32.8%
1 Month	-21.9%	-21.9%
3 Month	+3.4%	+3.4%
6 Month	-34.1%	-34.1%
1 Year	-36.1%	-36.1%

More News

Top movers in Monday's after hours session ↗

July 27, 2026

Via Chartmill

HeartSciences Files Its Fiscal 2026 Annual Report on Form 10-K

July 23, 2026

From HeartSciences Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

June 23, 2026

Via Benzinga

Fortitude and HeartSciences (Nasdaq: HSCS) Announce Business Combination, Aiming to Bring a Leading Vertically-Integrated Zcash Mining Platform to the Public Markets

June 23, 2026

From Fortitude Mining Holdings, Inc.

Via Business Wire

European Patent Granted for ECG-Based Assessment of Diastolic Function, Expands HeartSciences’ Patent Portfolio to More Than 45 Granted Patents

June 11, 2026

From HeartSciences Inc.

Via GlobeNewswire

HeartSciences Launches MyoVista Insights™ Version 1.3 with AI-ECG Algorithm Marketplace and First FDA-Cleared Algorithm

June 02, 2026

From HeartSciences Inc.

Via GlobeNewswire

HeartSciences Signs Commercial Agreement with North Shore Health, the First Hospital Deployment from the Cibolo Health Network

May 19, 2026

From HeartSciences Inc.

Via GlobeNewswire

HeartSciences Signs First SaaS Revenues Agreement following full launch of MyoVista Insights™

May 05, 2026

From HeartSciences Inc.

Via GlobeNewswire

HeartSciences Reminds Its Shareholders to Submit Their Vote at the Upcoming April 30, 2026, Annual Shareholders Meeting

April 14, 2026

From HeartSciences Inc.

Via GlobeNewswire

HeartSciences’ MyoVista Insights™ Receives Epic Toolbox Designation for ECG Management System Category

March 25, 2026

From HeartSciences Inc.

Via GlobeNewswire

HeartSciences to Present at Investor Summit Group Virtual Conference and Host Virtual One on One Investor Meetings

March 24, 2026

From HeartSciences Inc.

Via GlobeNewswire

Investor Summit Announces Q1 Presenter Line Up (Presentations 3/25, 1-on-1s 3/26)

March 20, 2026

Via ACCESS Newswire

HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update

March 16, 2026

From HeartSciences Inc.

Via GlobeNewswire

BioMedNewsBreaks — HeartSciences Inc. (NASDAQ: HSCS; HSCSW) Secures UWE As Exclusive ECG Education Reference Center

February 23, 2026

Via Investor Brand Network

University of West England Adopts HeartSciences’ MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference Center

February 05, 2026

From HeartSciences Inc.

Via GlobeNewswire

Cibolo Health Designates HeartSciences’ MyoVista Insights™ as Endorsed ECG Management Platform for Network of 123 Independent Hospitals

January 29, 2026

From HeartSciences Inc.

Via GlobeNewswire

HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update

December 15, 2025

From HeartSciences Inc.

Via GlobeNewswire

HeartSciences Announces FDA 510(k) Submission for MyoVista® wavECG™ Device

December 15, 2025

From HeartSciences Inc.

Via GlobeNewswire

HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1

December 11, 2025

From HeartSciences Inc.

Via GlobeNewswire

HeartSciences Inc (NASDAQ:HSCS) Reports Q1 FY2026 Results with Narrower-Than-Expected Loss and Positive Business Updates ↗

September 11, 2025

Via Chartmill

HeartSciences Provides Business Update and Reports First Quarter of Fiscal 2026 Financial Results

September 11, 2025

From HeartSciences Inc.

Via GlobeNewswire

HeartSciences Announces Conference Participation and Investor Webinar

August 15, 2025

From HeartSciences Inc.

Via GlobeNewswire

These stocks that are showing activity before the opening bell on Friday. ↗

August 01, 2025

Via Chartmill

Frequently Asked Questions

Is HeartSciences Inc. - Common Stock publicly traded?

Yes, HeartSciences Inc. - Common Stock is publicly traded.

What exchange does HeartSciences Inc. - Common Stock trade on?

HeartSciences Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for HeartSciences Inc. - Common Stock?

The ticker symbol for HeartSciences Inc. - Common Stock is HSCS on the Nasdaq Stock Market

What is the current price of HeartSciences Inc. - Common Stock?

The current price of HeartSciences Inc. - Common Stock is 2.110

When was HeartSciences Inc. - Common Stock last traded?

The last trade of HeartSciences Inc. - Common Stock was at 08/03/26 02:09 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.